Tibolone

Drug Profile

Tibolone

Alternative Names: Boltin; KB 889; Livial; Liviella; Livifem; ORG OD 14; Paraclim; Xyvion

Latest Information Update: 20 May 2017

Price : $50

At a glance

  • Originator Nourypharma; Organon
  • Developer Organon
  • Class Hormonal replacements; Norpregnenes; Osteoporosis therapies
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Menopausal syndrome; Postmenopausal osteoporosis

Most Recent Events

  • 05 Feb 2014 MSD Korea and Hanmi Pharmaceutical agree to co-promote tibolone in South Korea for Menopausal syndrome
  • 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
  • 19 Nov 2007 Organon has been acquired by Schering-Plough
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top